Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy

• Published in: PloS one Vol. 16; no. 10; p. e0258090
• Main Authors: Tezuka, Yuko, Eguchi-Ishimae, Minenori, Ozaki, Erina, Ito, Toshiyuki, Ishii, Eiichi, Eguchi, Mariko
• Format: Journal Article
• Language: English
• Published: San Francisco Public Library of Science 01.10.2021; Public Library of Science (PLoS)
• Subjects: Age; Analysis; Apoptosis; Biology and Life Sciences; Biopsy; Children; Cytokines; Deposition; Diseases; Fibroblast growth factors; Fibroblasts; Gene expression; Glomerulonephritis; Growth factors; Health aspects; IgA nephropathy; Immunoglobulin A; Inflammation; Kidney diseases; Laser arrays; Lesions; Medicine and Health Sciences; Pathogenesis; Patients; Pediatrics; Research and Analysis Methods; Tumor necrosis factor-TNF; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0258090

IgA nephropathy (IgAN) is the most common form of glomerulonephritis worldwide. Pediatric patients in Japan are diagnosed with IgAN at an early stage of the disease through annual urinary examinations. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and fibroblast growth factor-inducible 14 (Fn14) have various roles, including proinflammatory effects, and modulation of several kidney diseases; however, no reports have described their roles in pediatric IgAN. In this study, we performed pathological and immunohistochemical analyses of samples from 14 pediatric IgAN patients. Additionally, gene expression arrays of glomeruli by laser-captured microdissection were performed in hemi-nephrectomized high serum IgA (HIGA) mice, a model of IgA nephropathy, to determine the role of Fn14. Glomeruli with intense Fn14 deposition were observed in 80% of mild IgAN cases; however, most severe cases showed glomeruli with little or no Fn14 deposition. Fn14 deposition was not observed in obvious mesangial proliferation or the crescent region of glomeruli, but was detected strongly in the glomerular tuft, with an intact appearance. In HIGA mice, Fn14 deposition was observed mildly beginning at 11 weeks of age, and stronger Fn14 deposition was detected at 14 weeks of age. Expression array analysis indicated that Fn14 expression was higher in HIGA mice at 6 weeks of age, increased slightly at 11 weeks, and then decreased at 26 weeks when compared with controls at equivalent ages. These findings suggest that Fn14 signaling affects early lesions but not advanced lesions in patients with IgAN. Further study of the TWEAK/Fn14 pathway will contribute to our understanding of the progression of IgAN.